KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Retained Earnings (2016 - 2025)

Historic Retained Earnings for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to -$8.4 billion.

  • BeOne Medicines' Retained Earnings rose 81.08% to -$8.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 billion, marking a year-over-year increase of 81.08%. This contributed to the annual value of -$8.6 billion for FY2024, which is 809.82% down from last year.
  • Latest data reveals that BeOne Medicines reported Retained Earnings of -$8.4 billion as of Q3 2025, which was up 81.08% from -$8.5 billion recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Retained Earnings peaked at -$3.5 billion during Q1 2021, and registered a low of -$8.6 billion during Q4 2024.
  • Its 5-year average for Retained Earnings is -$6.9 billion, with a median of -$7.6 billion in 2023.
  • As far as peak fluctuations go, BeOne Medicines' Retained Earnings crashed by 5490.49% in 2022, and later skyrocketed by 81.08% in 2025.
  • Over the past 5 years, BeOne Medicines' Retained Earnings (Quarter) stood at -$5.1 billion in 2021, then plummeted by 39.47% to -$7.1 billion in 2022, then dropped by 12.45% to -$8.0 billion in 2023, then dropped by 8.1% to -$8.6 billion in 2024, then increased by 2.56% to -$8.4 billion in 2025.
  • Its Retained Earnings was -$8.4 billion in Q3 2025, compared to -$8.5 billion in Q2 2025 and -$8.6 billion in Q1 2025.